医学
中止
类风湿性关节炎
抗风湿药物
疾病
内科学
抗风湿药
临床试验
随机对照试验
关节炎
作者
Siri Lillegraven,Nina Paulshus Sundlisæter,Anna‐Birgitte Aga,Joseph Sexton,Daniel H. Solomon,Désirée van der Heijde,Espen A Haavardsholm
出处
期刊:JAMA
[American Medical Association]
日期:2023-03-28
卷期号:329 (12): 1024-1024
被引量:3
标识
DOI:10.1001/jama.2023.0492
摘要
This open-label randomized clinical trial assessed the 12-month risk of disease activity flares after discontinuation of conventional synthetic DMARDs (csDMARDs) compared with continuing half-dose csDMARDs in adult Norwegian patients with rheumatoid arthritis and excellent disease control.
科研通智能强力驱动
Strongly Powered by AbleSci AI